$SGP

Caution urged on scrapping system loss charge

Manila Electric Co. (Meralco) said it will join discussions on proposed amendments to the Electric Power Industry Reform Act (EPIRA) that could remove system loss charges from electricity bills. Meralco warned reforms should preserve distribution utility investment capacity. System loss is about 5% of bills in Meralco’s area. Meralco shares fell 4.66% to P562; SGP fell 0.36% to P28.

Original reporting
Published Jul 28, 2026, 4:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 28, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Caution urged on scrapping system loss charge — source image
Decision brief

The 30-second read

$SGPBearishMed
01

Why it matters

If system loss charges are removed without a direct subsidy or replacement recovery mechanism, distribution utilities and cooperatives could face funding gaps for network modernization and resilience, pressuring earnings assumptions and tariff negotiations.

02

Market read

Regulatory uncertainty around system loss charge removal is driving a same-day selloff in Meralco and SGP, with investors awaiting legislative and ERC clarity.

03

What to watch

The article cites a potential timeline of about a year and an ERC legal constraint (Section 43(f)), which may delay implementation and reduce near-term fundamental impact versus the market’s immediate reaction.

Relevance 6/10Novelty 5/10Timing: after-hours/next-session reaction to EPIRA system loss charge scrapping debate and related uncertainty

Background

The article frames a proposed amendment to EPIRA that could remove system loss charges from electricity bills, with Meralco and PHILRECA urging careful design to protect utility/EC investment capacity.

Company-level read

Ticker impact

$SGPBearishLow confidence
Context

Synergy Grid and Development Philippines (SGP), tied to NGCP, fell as investors reacted to uncertainty over potential EPIRA policy changes affecting system loss charges.

Expected impact

Likely continued volatility with downside risk if reforms reduce recoverable costs or shift regulatory frameworks.

Evidence & confidence

The text does not specify SGP’s direct revenue mechanism, but reports a same-day selloff attributed to policy uncertainty.

Market effects

Could reset expectations for regulated cost recovery in Philippine distribution utilities, with knock-on effects for capex plans and tariff modeling.

Most immediate read-across is to Metro Manila and nearby provinces served by Meralco, but the policy debate is national for DUs and ECs.

Limited direct global relevance; primarily a local regulatory/tariff risk for Philippine power infrastructure equities.

Counterpoint

System loss charges may be replaced by another mechanism (e.g., subsidies or alternative tariff components), limiting long-term earnings damage despite headline risk.

Key entities

  • Meralco

    Manila Electric Co. warns that scrapping system loss charges could undermine distribution utility sustainability and investment.

  • Synergy Grid and Development Philippines Inc. (SGP)

    Listed firm behind NGCP; shares fell with the market’s reaction to EPIRA reform uncertainty.

  • Energy Regulatory Commission (ERC)

    Chairman says Congress must amend EPIRA Section 43(f) before system loss charge recovery can be removed.

  • Philippine Rural Electric Cooperatives Association (PHILRECA)

    Supports VAT removal on system loss charges but warns against scrapping without subsidy, urging zero-rating across the supply chain.

  • National Grid Corp. of the Philippines (NGCP)

    Says it does not charge consumers for transmission technical system loss.

Related articles

$SGPMed

SpyGlass Pharma at Citigroup summit: glaucoma lens nears phase iii

SpyGlass Pharma (SGP) presented at Citigroup’s Biopharma Summit, outlining plans for its BIM-IOL drug-device platform. The company reported strong clinical data, with 95% of patients free of additional glaucoma therapy at three years in early trials. SpyGlass has $234 million in cash, expects Phase III trial completion in 2028, and aims for a 2029 launch. The company targets a market of 200,000 annual cataract procedures in the U.S. with glaucoma.

$SGPMed

SpyGlass Pharma Expands to Bigger HQ in Irvine

SpyGlass Pharma Inc. (Nasdaq: SGP) has moved to a larger headquarters in Irvine, accommodating up to 150 employees. The biopharmaceutical company, which went public in February, is focused on drug delivery solutions for chronic eye conditions. It is currently conducting Phase 3 trials for its lead product, the BIM-IOL system, with a target launch in 2029. The company's stock traded at $28.99 with a $970 million market cap, up 77% since its IPO. SpyGlass has also secured a new AMA Category III co

$SGPMed

SpyGlass Pharma, Inc. (SGP): Results of Operations and Financial Condition

SpyGlass Pharma, Inc. (SGP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates • Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of enrollment expected in 2027. •

$RAREHighAI 9/10

RARE Stock Jumps 13% — Extends Gains After-Hours As FDA Clears First Sanfilippo Gene Therapy

Ultragenyx Pharmaceutical Inc. (RARE) shares rose 13% during trading and 3% after-hours after the FDA approved Fayuvi, a gene therapy for Sanfilippo syndrome type A. The stock had previously hit a 52-week low. The therapy, priced at $3.95 million per patient, is Ultragenyx's second gene therapy approval. Retail sentiment on Stocktwits turned 'extremely bullish'.

$FICOMed

FICO Craters As Credit Score Monopoly Crumbles

Fair Isaac Corp. (FICO) shares fell as regulators allowed VantageScore to compete in U.S. mortgage lending, potentially reducing FICO's market dominance. Analysts highlight FICO's growing software revenues and customer retention as mitigating factors, but note risks from debt and increased competition.